Zithromax

Urethritis, Chancroid, Tonsillitis + 34 more

Treatment

32 FDA approvals

20 Active Studies for Zithromax

What is Zithromax

Azithromycin

The Generic name of this drug

Treatment Summary

Azithromycin is an antibiotic used to treat a wide range of bacterial infections, including respiratory, enteric and genitourinary infections. It is related to erythromycin, and is part of the azalide subclass of macrolides. It contains a 15-membered ring with a methyl-substituted nitrogen at the 9a position that prevents it from being broken down in the body. The FDA approved azithromycin in 1991 and in 2020, a French study found that a combination of azithromycin and hydroxychloroquine could be used to treat COVID-19. However

Zithromax

is the brand name

image of different drug pills on a surface

Zithromax Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Zithromax

Azithromycin

1994

541

Approved as Treatment by the FDA

Azithromycin, otherwise called Zithromax, is approved by the FDA for 32 uses including Bacterial Sinusitis and Sinusitis .

Bacterial Sinusitis

Sinusitis

Haemophilus Influenzae Infections

Genus Chlamydia

patients appropriate for oral therapy

Tonsillitis bacterial

genital ulcers caused by haemophilus ducreyi infection

Acute Otitis Media (AOM)

Streptococcus pyogenes

Streptococcal Pharyngitis

Tonsillitis streptococcal

unable to prescribe first line therapy for streptococcus pyogenes tonsillitis

Tonsillitis

Haemophilus ducreyi infection

Moraxella Catarrhalis Infection

Community Acquired Pneumonia (CAP)

Moraxella catarrhalis

ABDIC protocol

Adults

Streptococcus Pneumoniae Infections

Adult Patients

Genital Ulcer Disease (GUD)

Communicable Diseases

Staphylococcus (S.) Aureus Infection

Pneumococcal Infections

Pneumonia, Mycoplasma

Tonsillitis

Pediatric Patients

Otitis

Sore Throat

Streptococcus pyogenes

Streptococcus Agalactiae Infection

Effectiveness

How Zithromax Affects Patients

Macrolides are a type of drug used to treat bacterial infections by stopping the bacteria from growing and making proteins. Azithromycin has extra qualities that can help with respiratory diseases, and is sometimes used to treat these conditions.

How Zithromax works in the body

Azithromycin works by binding to the ribosomal proteins of bacteria, preventing them from making proteins. This stops bacteria from replicating and helps to control various bacterial infections.Azithromycin is more stable than other antibiotics, so it stays in the body longer and builds up higher concentrations in the tissues. This makes it more effective at fighting bacterial infections.

When to interrupt dosage

The quantity of Zithromax is contingent upon the diagnosed condition, including Streptococcus Agalactiae Infection, Chlamydia trachomatis and Genus Chlamydia. The measure of dosage is outlined in the table below, based on the route of administration.

Condition

Dosage

Administration

Streptococcus Agalactiae Infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Urethritis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Chancroid

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Conjunctivitis, Bacterial

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Communicable Diseases

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Otitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Tonsillitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Chlamydia trachomatis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Genus Chlamydia

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Genital Ulcer Disease (GUD)

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Haemophilus ducreyi infection

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Streptococcus pyogenes

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Moraxella catarrhalis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Uterine Cervicitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Sinusitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Adult Patients

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Tonsillitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Bacterial conjunctivitis

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Pneumonia, Mycoplasma

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Communicable Diseases

, 600.0 mg, 100.0 mg/mL, 500.0 mg, 10.0 mg/mL, 200.0 mg/mL, 500.0 mg/mL, 250.0 mg, 1000.0 mg, 50.0 mg/mL, 2000.0 mg, 1.0 %, 90.0 mg/mL, 120.0 mg/mL, 250.0 mg/mL

Oral, , Tablet, film coated, Tablet, film coated - Oral, Intravenous, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Tablet, Tablet - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Powder, for suspension - Oral, Powder, for suspension, Injection, Injection - Intravenous, Powder, for solution - Oral, Powder, for solution, Powder, for solution - Intravenous, Capsule, Capsule - Oral, Granule, for suspension, extended release - Oral, Granule, for suspension, extended release, Solution - Ophthalmic, Solution, For suspension, For suspension - Oral, Powder, for suspension - Parenteral, Parenteral, Suspension - Oral, Suspension, Tablet, coated, Tablet, coated - Oral

Warnings

Zithromax Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

Jaundice, Obstructive

Do Not Combine

prior azithromycin use

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

Severe Hypersensitivity Reactions

Do Not Combine

Azithromycin may interact with Pulse Frequency

There are 20 known major drug interactions with Zithromax.

Common Zithromax Drug Interactions

Drug Name

Risk Level

Description

Anagrelide

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Anagrelide.

Arsenic trioxide

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Arsenic trioxide.

Artemether

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Artemether.

Asenapine

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Asenapine.

Astemizole

Major

The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Astemizole.

Zithromax Toxicity & Overdose Risk

In rats, the lowest dose of azithromycin that causes toxicity is over 2000mk/kg. This drug could potentially cause heart rhythm problems and hearing loss, and has been linked to macrolide resistance. Liver and kidney damage have been reported in rare cases. Azithromycin is a pregnancy category B drug, meaning it has not been proven to be harmful to a fetus, but should be used with caution if pregnant. This drug may also be found in breast milk, so caution should be taken when nursing. Animal studies have not found any evidence of cancer or fertility problems caused by azithromycin.

image of a doctor in a lab doing drug, clinical research

Zithromax Novel Uses: Which Conditions Have a Clinical Trial Featuring Zithromax?

Currently, 9 active studies are examining the possibility of administering Zithromax for the management of Moraxella Catarrhalis Infection, Staphylococcus (S.) Aureus Infection and Communicable Diseases.

Condition

Clinical Trials

Trial Phases

Sinusitis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Staphylococcus (S.) Aureus Infection

2 Actively Recruiting

Phase 4, Phase 1

Conjunctivitis, Bacterial

0 Actively Recruiting

Streptococcus pyogenes

0 Actively Recruiting

Moraxella catarrhalis

0 Actively Recruiting

Streptococcus Agalactiae Infection

0 Actively Recruiting

Haemophilus Influenzae Infections

0 Actively Recruiting

Uterine Cervicitis

0 Actively Recruiting

Genital Ulcer Disease (GUD)

0 Actively Recruiting

unable to prescribe first line therapy for streptococcus pyogenes tonsillitis

0 Actively Recruiting

Bacterial conjunctivitis

0 Actively Recruiting

Streptococcus pyogenes

0 Actively Recruiting

Diarrhea

0 Actively Recruiting

Tonsillitis

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Pneumococcal Infections

0 Actively Recruiting

Pediatric Patients

0 Actively Recruiting

Adult Patients

0 Actively Recruiting

Chancroid

0 Actively Recruiting

Zithromax Reviews: What are patients saying about Zithromax?

5

Patient Review

3/20/2021

Zithromax for Bacterial Infection with Chronic Bronchitis

My doctor has said that I'll likely need to take this medication permanently. He believes it's helping my body build immunity. I'm concerned about long-term effects, but I will say that it has kept me from getting hospitalized for lung infections.

5

Patient Review

2/15/2021

Zithromax for Acute Bacterial Infection of the Sinuses

This medication was effective from the first dose. I experienced some bad stomach pain and diarrhea, but it was worth it to get rid of my sinus infection.

5

Patient Review

1/10/2022

Zithromax for Infection of the Middle Ear caused by Streptococcus

I waited a bit too long to see the doctor, but when I finally did and he prescribed this medication, it helped my breathing and cough within two days. We think I had the end of covid, had all shots. For me it's a life saver. I take with food otherwise I feel more nasua. I am taking 2nd prescription to make sure this gets rid of it. Not related to medicine but this virus has made me extremely weak. But feel like each day is better.

5

Patient Review

2/15/2021

Zithromax for Acute Bacterial Infection of the Sinuses

Though it caused some stomach pain and orange stool, this treatment was effective for my sinus infection. Z-packs have always worked great for me in the past, though sometimes I've needed a second round to completely eliminate the infection.

5

Patient Review

3/20/2021

Zithromax for Bacterial Infection with Chronic Bronchitis

My doctor has me on this medication long-term, claiming it builds up antibodies. I worry about potential side effects down the line, but I will say that it has kept me from returning to the hospital for lung infections.

5

Patient Review

1/10/2022

Zithromax for Infection of the Middle Ear caused by Streptococcus

I was very late in seeking medical help, but when I finally did and received this medication, it completely turned things around for me. Within two days of taking it, my breathing and coughing had greatly improved. I'm now on my second round of the prescription just to make sure that the virus is gone for good. I highly recommend this treatment.

4.7

Patient Review

2/8/2021

Zithromax for Acute Bacterial Infection of the Sinuses

I had a really blocked nose and sinuses. This medicine helped me clear it up quickly. I noticed an improvement on the second day, and by the fifth day I was perfectly fine. The only side effect I experienced was slight fatigue, which is understandable given the nature of the medication.

4.7

Patient Review

2/8/2021

Zithromax for Acute Bacterial Infection of the Sinuses

I had a really blocked nose and sinuses before taking this medication, but it helped me very quickly. I noticed an improvement on the second day and was perfectly fine by day five. The only side effect I experienced was slight fatigue, which is to be expected.

4

Patient Review

3/30/2021

Zithromax for Bacterial Infection with Chronic Bronchitis

Azithromycin has been effective for me in the past, however the second time I took it I experienced a range of uncomfortable symptoms. These side effects have made it difficult to keep taking the medication, but hopefully with time they will subside and I can continue treatment.

4

Patient Review

12/3/2019

Zithromax for Bacterial Infection with Chronic Bronchitis

I was diagnosed with an upper respiratory infection and was prescribed Azithromycin 250 mg tables for a 5 day treatment. The pharmacy tech said to call my ATU clinic for adjustments for Warfarin. ATU clinic had me adjust the warfarin for the 5 days I am on the Zpack and was told to watch for any bleeding or bruising more than normal for the next week. Warfarin and Azithromycin do not act well together, so adjustments need to be made temporarily.

4

Patient Review

12/3/2019

Zithromax for Bacterial Infection with Chronic Bronchitis

I was diagnosed with an upper respiratory infection and was prescribed Azithromycin 250 mg tables for a 5 day treatment. The pharmacy tech said to call my ATU clinic for adjustments for Warfarin. ATU clinic had me adjust the warfarin for the 5 days I am on the Zpack and was told to watch for any bleeding or bruising more than normal for the next week.

4

Patient Review

3/30/2021

Zithromax for Bacterial Infection with Chronic Bronchitis

This drug seems to work well against the coughs I get, however the side effects are really not worth it. The second time I took it was much worse than the first and I had basically every symptom imaginable. Not something I'd recommend taking frequently.

3.7

Patient Review

4/13/2022

Zithromax for Chlamydia Trachomatis Infection of Female Pelvic Organs

Forgot to eat before taking this, and then ate spicy food afterwards. Big mistake! I felt incredibly nauseous and ended up vomiting. Still feeling dizzy now, but lesson learned: make sure to eat something beforehand and drink lots of water.

3.7

Patient Review

4/13/2022

Zithromax for Chlamydia Trachomatis Infection of Female Pelvic Organs

Make sure you eat something before taking this medication, otherwise you'll end up feeling nauseous and might even vomit. I made the mistake of having spicy food after taking it and paid for it dearly. Still recovering from the dizziness, but lesson learned!

3.3

Patient Review

1/4/2020

Zithromax for Strep Throat

I was pleasantly surprised at how much better my throat felt after just one day. By the second, my tonsils were visibly smaller. And by the third, the infection seemed to be gone. But then I started feeling really sick and ended up vomiting. I'm stopping the treatment now and hoping that the bacteria is completely cleared up.

3.3

Patient Review

1/4/2020

Zithromax for Strep Throat

I was really pleased with how my throat felt better after the first day. By the second, my tonsils had shrunk down noticeably. However, by the third day I started feeling really sick and ended up vomiting. I'm done with this treatment now and hoping that the infection is cleared up.

3

Patient Review

1/7/2022

Zithromax for Acute Bacterial Infection of the Sinuses

I started to experience a burning sensation in my stomach after taking this medication for sinus congestion. I made sure to eat before taking it, as per the instructions, but still experienced the side effect. Despite this, the medication did help clear up my sinus infection.

3

Patient Review

1/7/2022

Zithromax for Acute Bacterial Infection of the Sinuses

I started to experience a burning feeling in my stomach 20 minutes after taking the Z-PAC on my second day. other than that, it's been helpful for clearing up my sinus congestion. I hope I don't have to take it again, but if necessary, I would.

2.7

Patient Review

5/27/2021

Zithromax for infection caused by bacteria

I was diagnosed with strep throat, which seemed to go away after the third day. However, as soon as I stopped taking the medication, the infection reappeared and actually spread to the other side of my mouth. I've been prescribed a second round of this treatment, but it doesn't seem to be working any better than the first time (if not worse). I'm concerned that the strep might have become immune to this medication.

2.7

Patient Review

5/27/2021

Zithromax for infection caused by bacteria

I was diagnosed with strep throat, which seemed to clear up after a few days. However, as soon as I stopped taking the medication, the infection came back--and it was worse than before. I'm now on my second round of antibiotics, and there doesn't seem to be any improvement. If anything, I think the strep might be becoming resistant to this particular medication. The only reason I'm still taking it is because I'm allergic to amoxicillin.

2.3

Patient Review

6/14/2022

Zithromax for Bronchitis caused by the Bacteria Haemophilus Influenzae

I was prescribed this medication for bronchitis, and while it did take the heaviness in my chest and clear up most of the mucus, I have been experiencing dizziness ever since starting it! I am currently at the ER because it’s been three days and it’s making me anxious that I can’t even sleep.

2.3

Patient Review

6/14/2022

Zithromax for Bronchitis caused by the Bacteria Haemophilus Influenzae

I was prescribed this medication for bronchitis, and while it did take the heaviness in my chest and clear up most of the mucus, I have been experiencing debilitating dizziness ever since starting it! Three days later, I'm still struggling to even sleep.

1.7

Patient Review

5/11/2021

Zithromax for Acute Bacterial Infection of the Sinuses

I had to go to the emergency room a few hours after taking this medication. My blood pressure and heart rate soared, causing me great anxiety. The cardiologist who saw me was just as perplexed as I was.

1.7

Patient Review

5/11/2021

Zithromax for Acute Bacterial Infection of the Sinuses

I had an adverse reaction a few hours after taking this for a sinus infection. My heart rate and blood pressure went up to 178/98 blood pressure and 130 pulse at resting. They are usually normal. I was kept overnight for evaluation. The cardiologist that saw me had no idea why this happened.

1

Patient Review

11/17/2021

Zithromax for Middle Ear Infection

After just two days on this treatment, I felt so awful that I had to go to the emergency room. I was dizzy and in a lot of pain, shaking uncontrollably. Definitely not worth it.

1

Patient Review

8/3/2019

Zithromax for infection caused by bacteria

I had terrible stomach pains and vomiting after taking this drug for a Bartholin's cyst. This has happened to me before with this medication, so I will never use it again.

1

Patient Review

11/17/2021

Zithromax for Middle Ear Infection

After just two days on this medication, I went to the ER feeling like I was going to die. Dizzy, with stomach pain and shaking uncontrollably. Needless to say, I won't be taking this again.

1

Patient Review

8/3/2019

Zithromax for infection caused by bacteria

Do not bother with this drug; it gave me terrible stomach pains and vomiting when I took it for a Bartholin's cyst. This was also my experience the first time I took it for another infection.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about zithromax

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How fast does Zithromax work?

"The most common side effects of Zithromax are diarrhea, abdominal pain, nausea, and vomiting. Generally, it takes about five days for the full effect."

Answered by AI

What infections are treated with Zithromax?

"Otitis media, tonsillitis, laryngitis, bronchitis, pneumonia, and sinusitis are all caused by bacteria."

Answered by AI

What is Zithromax used for?

"Azithromycin is used to treat bacterial infections. It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu)."

Answered by AI

Is Zithromax a penicillin?

"Zithromax is not a penicillin. It is a macrolide antibiotic. Macrolides work by inhibiting protein synthesis and blocking the assembly of the 50S ribosomal subunit. This structure helps coordinate protein synthesis in cells."

Answered by AI

Clinical Trials for Zithromax

Image of Grady Memorial Hospital in Atlanta, United States.

Point-of-care Testing for Sexually Transmitted Infections

Any Age
Female
Atlanta, GA

The goal of this clinical trial is to learn if point-of-care tests (POCTs) for sexually transmitted infections (STIs) improve the timely treatment of syphilis, chlamydia, gonorrhea, and trichomonas in pregnant women. It will also learn about the feasibility, acceptability, and cost-effectiveness of implementing POCTs in a large safety-net hospital setting. The main questions it aims to answer are: * Do POCTs reduce delays in STI treatment compared with standard laboratory-based testing? * What barriers, facilitators, and processes affect POCT implementation in prenatal and obstetric care? * What are the costs and cost-effectiveness of POCTs compared with standard testing? Participants will: * Complete a baseline survey and receive either POCTs (fingerstick blood draw or vaginal swab) or standard laboratory STI testing. * If diagnosed with an STI, complete a follow-up survey approximately one month later. * Stakeholders (providers, hospital leadership, and public health officials) will complete interviews to inform implementation strategies.

Waitlist Available
Has No Placebo

Grady Memorial Hospital

Kristin Wall, PhD

Image of Centre for Urban Innovation (CUI-109), School of Nutrition, Toronto Metropolitan University in Toronto, Canada.

White Potatoes for Glycemic Responses

18 - 65
All Sexes
Toronto, Canada

The purpose of this study is to evaluate the interaction between white potato consumption and meal timing on glycemic response, subjective appetite, and energy intake in adults. The investigators hypothesize that white potatoes will modulate glycemic response, enhance satiety, and mitigate subsequent meal consumption and overall food intake when compared with meals containing low glycemic carbohydrates. Furthermore, they anticipate that the timing of white potato consumption will yield differential effects, with breakfast consumption exerting a more pronounced impact on satiety and subsequent food intake reduction compared to dinner consumption.

Recruiting
Has No Placebo

Centre for Urban Innovation (CUI-109), School of Nutrition, Toronto Metropolitan University

Have you considered Zithromax clinical trials?

We made a collection of clinical trials featuring Zithromax, we think they might fit your search criteria.
Go to Trials
Image of Washington University in St. Louis in St Louis, United States.

Adapted HARP for Falls Prevention

45 - 64
All Sexes
St Louis, MO

The Home Hazard Removal Program (HARP) is an effective fall prevention intervention program which targets home hazard identification/removal. In this study the investigators will examine the effectiveness and implementation potential of HARP, adapted for PwD. Investigators will conduct a pilot randomized control trial (RCT) to test the implementation, cost, and preliminary efficacy of an adapted version of HARP for community-dwelling PwD. The single-blinded feasibility RCT will randomize 40 participants to treatment (adapted HARP) and 40 to a waitlist control group. Data on specific types of fall hazards and resulting home modifications as well as falls and fall-related injuries (collected monthly over 12 months) and fear of falling (collected at baseline and 12 months) will inform the preliminary efficacy of adapted HARP among PwD. To ensure usefulness, relevance, and broad dissemination of findings, the investigators will adopt a "designing for implementation and dissemination" approach. The RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance) framework will guide intervention adaptation, trial design, and future implementation. The Practical Robust Implementation and Sustainability Model (PRISM) guides study development by identifying multi-level contextual factors hypothesized to affect the RE-AIM outcomes.

Recruiting
Has No Placebo

Washington University in St. Louis

Susan L Stark, PhD

Image of Children's Healthcare of Atlanta in Atlanta, United States.

Antibiotic Strategies for Pneumonia in Children

12 - 71
All Sexes
Atlanta, GA

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.

Recruiting
Has No Placebo

Children's Healthcare of Atlanta (+3 Sites)

Todd Florin, MD, MSCE

Image of USC Voice Center in Arcadia, United States.

Voice Therapy for Age-Related Voice Change

18+
All Sexes
Arcadia, CA

This study compares how well voice therapy works when delivered in-person versus through telehealth for older adults with age-related voice problems. Researchers are testing whether Phonation Resistance Training Exercises (PhoRTE®) can be just as effective when delivered remotely as when done face-to-face, which could make treatment more accessible and affordable for seniors. The two primary hypotheses are: 1. Does voice therapy (called PhoRTE®) work as well through video calls as it does face-to-face? 2. Can online therapy be a more accessible way for older adults to get help for their voice problems? Adults aged 55 or older with voice changes and an applicable diagnosis will be randomly assigned to receive either in-person or telehealth therapy, consisting of four 45-minute sessions. After treatment, researchers will measure improvements through: * Changes in voice function * Patient reports about their voice * Scientific measurements of voice quality * Patient satisfaction with treatment * Impact on quality of life The results will help determine if telehealth can be a good alternative to in-person voice therapy, especially important as telehealth coverage may be changing.

Waitlist Available
Has No Placebo

USC Voice Center (+3 Sites)

Aaron Rothbart, PhD

Have you considered Zithromax clinical trials?

We made a collection of clinical trials featuring Zithromax, we think they might fit your search criteria.
Go to Trials
Image of Loma Linda University Medical Center Troesh Medical Campus in Loma Linda, United States.

Endotracheal Suctioning for Procedural Pain

18+
All Sexes
Loma Linda, CA

The goal of this experimental study is to understand if endotracheal tube (ETT) suctioning increases pain and causes stress on the body in intubated adult ICU patients. These patients are already on ventilators, which means they need suctioning to keep their airways clear, but this procedure may be uncomfortable and cause stress. The main questions this study aims to answer are: Does ETT suctioning raise pain levels as measured by the Critical-Care Pain Observation Tool (CPOT)? Does ETT suctioning increase certain chemicals in the blood (hypoxanthine, xanthine, and uric acid) that show stress and lack of oxygen in the body? Researchers will compare patients who have ETT suctioning (intervention group) with those who do not have suctioning during the study period (control group) to see if there are differences in pain and blood markers of stress. Participants will: Have pain measured before and after suctioning using the CPOT. Have blood samples taken from an existing line at three time points: 5 minutes before, 5 minutes after, and 30 minutes after suctioning. Provide demographic information (like age, gender, and diagnosis) from medical records. This research will help improve how pain is managed for ICU patients who cannot speak for themselves, potentially leading to better pain relief methods in the future.

Recruiting
Has No Placebo

Loma Linda University Medical Center Troesh Medical Campus

Elizabeth Johnston Taylor, PhD, FAAN

Have you considered Zithromax clinical trials?

We made a collection of clinical trials featuring Zithromax, we think they might fit your search criteria.
Go to Trials